Nkarta to participate at upcoming investor conferences

South san francisco, calif., nov. 02, 2022 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies to treat cancer, today announced its participation at three upcoming investor conferences:

NKTX Ratings Summary

NKTX Quant Ranking